You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Targeted Immune Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Myelodysplastic Syndrome
  • Gemtuzumab Ozogamicin
  • Valhalla, New York
    New York Medical College
Sep 26, 2022

Immune Checkpoint Inhibitor Monotherapy or Combined With

Not yet recruiting
  • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Department of Minimally Invasive and Interventional Radiology, L
Jan 30, 2023

Healthcare Resource Utilization and Costs of Immune Checkpoint

Completed
  • Melanoma
    • East Hanover, New Jersey
      Novartis
    May 12, 2023

    Adverse Events-related Healthcare Resource Utilization and Costs

    Completed
    • Melanoma
    • East Hanover, New Jersey
      Novartis Pharmaceuticals
    Jan 27, 2023

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

    Completed
    • Acute Myelogenous Leukemia
    • +2 more
    • New York, New York
      Columbia University Medical Center
    Aug 4, 2021

    Liver Transplantation, Hepatocellular Carcinoma Trial in Guangzhou (FOLFOX-HAIC, Lenvatinib, PD-1 inhibitor)

    Not yet recruiting
    • Liver Transplantation
    • Hepatocellular Carcinoma
    • FOLFOX-HAIC
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    Jul 26, 2022

    Lymphoma Trial in Seattle (biological, other, procedure)

    Not yet recruiting
    • Lymphoma
    • Immune Globulin Infusion (Human), 10% Solution
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jul 21, 2023

    Advanced Cancer, Metastatic Cancer Trial in Shanghai (biological, device, drug)

    Recruiting
    • Advanced Cancer
    • Metastatic Cancer
    • Autologous Adoptive immune cells
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Pudong Medical Center
    Jun 24, 2022

    Gastric Cancer Trial (Penpulimab combination with anlotinib and chemo)

    Not yet recruiting
    • Gastric Cancer
    • Penpulimab combination with anlotinib and chemotherapy
    • (no location specified)
    May 17, 2022

    Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)

    Recruiting
    • Cutaneous Melanoma
    • Blood sample
    • Cutaneous melanoma biopsy
    • Paris, Ile De France, France
      Dermatology department
    Oct 24, 2022

    Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

    Recruiting
    • Lung Neoplasms
    • +3 more
    • Observation
    • Shanghai, China
      Shanghai Chest Hospital
    Mar 14, 2022

    Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

    Recruiting
    • Recurrent Neuroblastoma
    • +3 more
    • Palo Alto, California
    • +3 more
    Jan 25, 2023

    Investigating the Impact of Proactive Palliative Care

    Active, not recruiting
    • Metastatic Solid Tumor Cancers
    • Locally Advanced Solid Tumor Cancers
    • Expectations Survey (CanCORS)
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Aug 2, 2022

    Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Active, not recruiting
    • Adult Acute Lymphoblastic Leukemia in Remission
    • +14 more
    • radiation therapy
    • +8 more
    • Columbus, Ohio
      Arthur G. James Cancer Hospital and Solove Research Institute at
    Oct 7, 2022

    Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

    Recruiting
    • Hepatitis B, Chronic
    • Edegem, Belgium
    • +47 more
    Jan 24, 2023

    Identify Biomarkers of Pulmonary Toxicity for Immune Checkpoint

    Recruiting
    • Pneumonitis, Interstitial
    • +2 more
    • Immune checkpoint blockade
    • +2 more
    • Leuven, Flemish Brabant, Belgium
      Universitaire Ziekenhuizen Leuven
    Mar 18, 2021

    MDD, Inflammation Trial in Duffel, Brussels, Leuven (Celecoxib, Minocyclin, Placebo)

    Not yet recruiting
    • Major Depressive Disorder
    • Inflammation
    • Duffel, Antwerpen, Belgium
    • +2 more
    Dec 8, 2022

    Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)

    Not yet recruiting
    • Herpes Simplex
    • HSVTI Formulation 1
    • +2 more
    • Tokyo, Japan
      GSK Investigational Site
    Aug 4, 2023

    Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as

    Completed
    • Colorectal Cancer Metastatic
    • Targeted agent
    • (no location specified)
    Aug 31, 2023

    Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
    • +4 more
    • Guangzhou, Guangdong, China
      SUN Yat-sen University Cancer Center
    Sep 11, 2023

    Postural Tachycardia Syndrome Trial in La Jolla (Time restricted eating)

    Recruiting
    • Postural Tachycardia Syndrome
    • Time restricted eating
    • La Jolla, California
      Altman Clinical and Translational Research Institute
    Aug 3, 2022

    Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

    Recruiting
    • Relapse/Refractory Multiple Myeloma
    • DeepTag-GPRC5D Targeted CAR T-cells
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Oct 10, 2023

    Pulmonary Hypertension Trial

    Not yet recruiting
    • Pulmonary Hypertension
      • (no location specified)
      Nov 12, 2023

      Efficacy of Targeted Therapy for NSCLC

      Recruiting
      • Evaluation
      • +2 more
      • RecistTM criteria
      • Chongqing, Chongqing, China
        Cancer Center, Dapping Hospital, Army Medical Center of PLA
      Nov 15, 2023

      /or PD-1 Inhibitors for Unresectable Intrahepatic

      Completed
      • Intrahepatic Cholangiocarcinoma
      • hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
      • GuangZhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Aug 7, 2022